JetBlue Airways Corporation vs 10X Genomics Inc — how do they compare? JetBlue Airways Corporation trades at $5.81 (market cap $2.19B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 3.5× JetBlue Airways Corporation's market cap, and 10X Genomics Inc is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| JBLU | TXG | |
|---|---|---|
Market Cap | $2.19B | $7.61B |
Sector | Industrials | Health |
52-Week High | $6.46 | $58.57 |
52-Week Low | $4.03 | $11.34 |
Enterprise Value | $9.56B | $7.14B |
Trailing returns across standard periods
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →